A genetic variant in primary miR-378 is associated with risk and prognosis of hepatocellular carcinoma in a Chinese population.
BACKGROUND: MiR-378 has been reported to be related to cell survival, tumor growth and angiogenesis and may participate in hepatocellular carcinoma (HCC) development and prognosis. Genetic variants in primary miR-378 (pri-miR-378) may impact miR-378 expression and contribute to HCC risk and survival...
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
Public Library of Science (PLoS)
2014-01-01
|
| coleção: | PLoS ONE |
| Acesso em linha: | http://europepmc.org/articles/PMC3994025?pdf=render |
| _version_ | 1828239465637740544 |
|---|---|
| author | Jiaze An Jibin Liu Li Liu Yao Liu Yun Pan Mingde Huang Fuzhen Qi Juan Wen Kaipeng Xie Hongxia Ma Hongbing Shen Zhibin Hu |
| author_facet | Jiaze An Jibin Liu Li Liu Yao Liu Yun Pan Mingde Huang Fuzhen Qi Juan Wen Kaipeng Xie Hongxia Ma Hongbing Shen Zhibin Hu |
| author_sort | Jiaze An |
| collection | DOAJ |
| description | BACKGROUND: MiR-378 has been reported to be related to cell survival, tumor growth and angiogenesis and may participate in hepatocellular carcinoma (HCC) development and prognosis. Genetic variants in primary miR-378 (pri-miR-378) may impact miR-378 expression and contribute to HCC risk and survival. This study aimed to assess the associations between a genetic variant in primary miR-378 and HCC susceptibility and prognosis. METHODS: We conducted a case-control study to analyze the association of rs1076064 in pri-miR-378 with hepatocellular carcinoma risk in 1300 HCC patients with positive hepatitis B virus (HBV) and 1344 HBV carriers. Then, we evaluated the correlation between the polymorphism and hepatocellular carcinoma prognosis in 331 HCC patients at either intermediate or advanced stage without surgical treatment. RESULTS: The variant genotypes of rs1076064 were associated with a decreased HCC risk in HBV carriers [Adjusted odds ratio (OR) = 0.90, 95% confidence intervals (CI) = 0.81-1.00, P = 0.047]. Moreover, HCC patients with the variant genotypes were associated with a better survival [Adjusted hazard ratio (HR) = 0.70, 95% CIs = 0.59-0.83, P<0.0001 in an additive genetic model]. The reporter gene assay showed that the variant G allele of rs1076064 exerted higher promoter activity than the A allele. CONCLUSIONS: These findings indicate that rs1076064 may be a biomarker for HCC susceptibility and prognosis through altering pri-miR-378 transcription. |
| first_indexed | 2024-04-12T21:23:05Z |
| format | Article |
| id | doaj.art-f162868ead3c44eca9d8f4dbfa928b51 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-12T21:23:05Z |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-f162868ead3c44eca9d8f4dbfa928b512022-12-22T03:16:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0194e9370710.1371/journal.pone.0093707A genetic variant in primary miR-378 is associated with risk and prognosis of hepatocellular carcinoma in a Chinese population.Jiaze AnJibin LiuLi LiuYao LiuYun PanMingde HuangFuzhen QiJuan WenKaipeng XieHongxia MaHongbing ShenZhibin HuBACKGROUND: MiR-378 has been reported to be related to cell survival, tumor growth and angiogenesis and may participate in hepatocellular carcinoma (HCC) development and prognosis. Genetic variants in primary miR-378 (pri-miR-378) may impact miR-378 expression and contribute to HCC risk and survival. This study aimed to assess the associations between a genetic variant in primary miR-378 and HCC susceptibility and prognosis. METHODS: We conducted a case-control study to analyze the association of rs1076064 in pri-miR-378 with hepatocellular carcinoma risk in 1300 HCC patients with positive hepatitis B virus (HBV) and 1344 HBV carriers. Then, we evaluated the correlation between the polymorphism and hepatocellular carcinoma prognosis in 331 HCC patients at either intermediate or advanced stage without surgical treatment. RESULTS: The variant genotypes of rs1076064 were associated with a decreased HCC risk in HBV carriers [Adjusted odds ratio (OR) = 0.90, 95% confidence intervals (CI) = 0.81-1.00, P = 0.047]. Moreover, HCC patients with the variant genotypes were associated with a better survival [Adjusted hazard ratio (HR) = 0.70, 95% CIs = 0.59-0.83, P<0.0001 in an additive genetic model]. The reporter gene assay showed that the variant G allele of rs1076064 exerted higher promoter activity than the A allele. CONCLUSIONS: These findings indicate that rs1076064 may be a biomarker for HCC susceptibility and prognosis through altering pri-miR-378 transcription.http://europepmc.org/articles/PMC3994025?pdf=render |
| spellingShingle | Jiaze An Jibin Liu Li Liu Yao Liu Yun Pan Mingde Huang Fuzhen Qi Juan Wen Kaipeng Xie Hongxia Ma Hongbing Shen Zhibin Hu A genetic variant in primary miR-378 is associated with risk and prognosis of hepatocellular carcinoma in a Chinese population. PLoS ONE |
| title | A genetic variant in primary miR-378 is associated with risk and prognosis of hepatocellular carcinoma in a Chinese population. |
| title_full | A genetic variant in primary miR-378 is associated with risk and prognosis of hepatocellular carcinoma in a Chinese population. |
| title_fullStr | A genetic variant in primary miR-378 is associated with risk and prognosis of hepatocellular carcinoma in a Chinese population. |
| title_full_unstemmed | A genetic variant in primary miR-378 is associated with risk and prognosis of hepatocellular carcinoma in a Chinese population. |
| title_short | A genetic variant in primary miR-378 is associated with risk and prognosis of hepatocellular carcinoma in a Chinese population. |
| title_sort | genetic variant in primary mir 378 is associated with risk and prognosis of hepatocellular carcinoma in a chinese population |
| url | http://europepmc.org/articles/PMC3994025?pdf=render |
| work_keys_str_mv | AT jiazean ageneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT jibinliu ageneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT liliu ageneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT yaoliu ageneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT yunpan ageneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT mingdehuang ageneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT fuzhenqi ageneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT juanwen ageneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT kaipengxie ageneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT hongxiama ageneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT hongbingshen ageneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT zhibinhu ageneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT jiazean geneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT jibinliu geneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT liliu geneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT yaoliu geneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT yunpan geneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT mingdehuang geneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT fuzhenqi geneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT juanwen geneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT kaipengxie geneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT hongxiama geneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT hongbingshen geneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation AT zhibinhu geneticvariantinprimarymir378isassociatedwithriskandprognosisofhepatocellularcarcinomainachinesepopulation |